Extracolonic findings observed on computed tomography colonography (CTC) scans of cancer patients might identify undetected malignancy more often than previously thought, according to a new study. 

Research published this week in Clinical Imaging that highlights the prevalence of extracolonic findings, as well as the clinical outcomes, found that more than 8% of CTC scans on oncological patients uncover “potentially important” imaging anomalies, which sometimes resulted in the discovery of previously unidentified cancers. 

“While CT images provide critical information on the colon, they also yield information on extracolonic structures (from the lung bases to the pelvis) despite the low radiation dose and frequent lack of intravenous contrast,” corresponding author Marc J. Gollub, of the Department of Radiology at Memorial Memorial Sloan Kettering Cancer Center in New York, and co-authors said. “From the early days of CTC, radiologists have faced the dilemma of how to deal with extracolonic findings.” 

While extracolonic findings have been researched in symptomatic patients or patients undergoing CTC cancer screenings, their frequency and impact on patients with cancer is relatively undetermined, the authors suggested. Since cancer patients frequently undergo imaging for surveillance, the researchers hypothesized that extracolonic findings in this population of individuals would be minimal compared to the general population. 

They retrospectively analyzed CTC exams from 855 patients who underwent the scan between February 2000 and April 2016 with the help of two radiologists. One reader, who was blinded to the data, classified the extracolonic findings using C-RADS (E1-E4), while another unblinded radiologist also completed a review. The unblinded radiologist focused on E4, or “potentially important,” classifications when reviewing the medical records to determine if the findings were previously unknown and then reclassified them as either clinically important or unimportant.